{"id":"W4410820763","doi":"10.1200/jco.2025.43.16_suppl.tps5632","title":"Randomized study evaluating optimal dose, efficacy and safety of E7386 + lenvatinib versus treatment of physicians’ choice in advanced/recurrent endometrial carcinoma previously treated with anti–PD-(L)1 immunotherapy.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Lenvatinib; Immunotherapy; Oncology; Internal medicine; Randomized controlled trial; Endometrial cancer; Gynecology; Carcinoma; Cancer; Sorafenib; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003397431,0.00126569,0.002811587,0.0004174164,0.0004317109,0.001191256,0.0009147035,0.002153333,0.008535182],"category_scores_gemma":[0.003616475,0.0007197483,0.001977809,0.000480487,0.001260553,0.001244702,0.0005782763,0.003626093,0.001088887],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00137848,"about_ca_system_score_gemma":0.001594235,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001187221,"about_ca_topic_score_gemma":0.002625162,"domain_scores_codex":[0.9980666,0.001234908,0.00009779922,0.0002455788,0.0001049382,0.0002502366],"domain_scores_gemma":[0.9970769,0.0008891905,0.0006871481,0.0002292779,0.0001578574,0.0009597297],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9888906,0.004985556,0.0006327686,0.0000824783,0.0004114789,0.0000176922,0.00001256281,0.0001874601,0.0005762324,0.00004061473,0.0003344944,0.003827918],"study_design_scores_gemma":[0.8613743,0.1336274,0.002627088,0.0000197389,0.0004841338,0.00002984985,0.000021586,0.0006577987,0.0002414927,0.0001886502,0.0007134218,0.00001446356],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.985495,0.002083364,0.0006049307,0.0009056143,0.0006660367,0.006173342,0.00115665,0.0000861315,0.002828879],"genre_scores_gemma":[0.9882466,0.0006844616,0.001255323,0.001555877,0.0003732133,0.004618795,0.0009886258,0.00001785657,0.002259304],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008535182,"threshold_uncertainty_score":0.02855301,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1155554495727798,"score_gpt":0.4839434033552135,"score_spread":0.3683879537824338,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}